Never-Ending: Moderna Asks FDA to Authorize COVID Vaccine for Children Ages 6 Months to 5 Years Old

The two-dose vaccine was about 51% effective against infection from the omicron variant in children under 2 years old and about 37% effective among 2- to 5-year-old kids, according to Moderna.

Dr. Paul Burton, Moderna’s chief medical officer, said the vaccines induced high levels of antibodies in the kids, which should correlate to a high level of protection against severe illness.

The FDA has promised to move quickly to authorize shots for infants, toddlers and preschoolers once the vaccine makers submit complete applications.